7/8/2020 8:42:45 AM
CorMedix Says All Of The Modules For Defencath NDA Submitted To FDA
5/11/2020 8:41:09 AM
CorMedix Appoints Matt David As EVP And CFO
10/16/2019 8:20:24 AM
CorMedix Completes CMC Interaction With FDA; Pre-NDA Meeting Scheduled
9/26/2019 8:19:52 AM
CorMedix Reports Exercises Of Outstanding Warrants
7/9/2019 8:20:52 AM
CorMedix Reports Encouraging FDA Feedback On Neutrolin LOCK-IT-100 Data